A number of pharmaceutical companies have begun to unveil medical advances in fighting the coronavirus after almost a year of its emergence, including Pfizer Inc. and BioNTech SE who appear to be at the forefront with 95 percent vaccine efficiency in the final analysis of clinical trial data and pos
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp